Literature DB >> 30904074

Placental passage of eculizumab and complement blockade in a newborn.

Caroline Duineveld1, Kioa L Wijnsma2, Elena B Volokhina3, L P Bert van den Heuvel3, Nicole C A J van de Kar2, Jack F M Wetzels4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30904074     DOI： 10.1016/j.kint.2019.01.012

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  4 in total

1.  Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report.

Authors:  Michael J Fassett; Adrian L Hernandez Lopez
Journal:  Case Rep Womens Health       Date:  2021-02-11

2.  Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy.

Authors:  Natalja Haninger-Vacariu; Christof Aigner; Renate Kain; Zoltán Prohászka; Martina Gaggl; Georg A Böhmig; Leah Charlotte Piggott; Raute Sunder-Plassmann; Gere Sunder-Plassmann; Alice Schmidt
Journal:  Kidney Med       Date:  2020-02-22

3.  Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.

Authors:  Gaby A M Eliesen; Joris van Drongelen; Petra H H van den Broek; Andrei Sarlea; Olivier W H van der Heijden; Saskia Langemeijer; Rick Greupink; Elena B Volokhina; Frans G M Russel
Journal:  Br J Clin Pharmacol       Date:  2020-11-02       Impact factor: 4.335

Review 4.  Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder.

Authors:  Trygve Holmøy; Rune Alexander Høglund; Zsolt Illes; Kjell-Morten Myhr; Øivind Torkildsen
Journal:  J Neurol       Date:  2020-10-03       Impact factor: 6.682
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.